BioVenture Builder Now Open for Applications

A new long-term support programme for early-stage biotech ventures in the Netherlands

Transforming breakthrough science into a successful therapeutic venture is one of the most complex challenges in the life sciences sector. High development costs, strict regulation, scientific uncertainty and long timelines create a difficult path for founders at the earliest stages.

To address this, the Brabant Development Agency (BOM) has launched BioVenture Builder — a specialised programme that helps drug discovery and therapeutic development teams build robust, investment-ready biotech companies.

BioVenture Builder is now accepting applications.

What BioVenture Builder Offers

BioVenture Builder provides structured, long-term support for preclinical and early clinical biotech ventures. Selected teams gain access to:

✔ Deep 1-on-1 Venture Development

Tailored guidance to refine your business model, competitive positioning, development roadmap and value creation strategy.

✔ Scientific, Regulatory & Clinical Strategy Support

Expert input across:

• Preclinical validation

• CMC and manufacturing strategy

• Regulatory planning (EMA/FDA)

• Health Technology Assessment (HTA)

• Intellectual property strategy

✔ Early Access to Key Stakeholders

Founders work directly with:

• Clinical and scientific Key Opinion Leaders

• Regulatory and CMC specialists

• Investors and funding partners

• Industry strategists and business developers

✔ A Roadmap Toward Follow-on Funding

With a strong focus on:

• Building credible investor materials

• Identifying strategic partners

• Preparing for early-stage funding rounds

• Connecting to Dutch and international biotech investors

Who Should Apply?

BioVenture Builder is designed for founders working on:

• Novel therapeutic modalities (biologics, small molecules, ATMPs)

• Drug discovery platforms or enabling technologies

• Preclinical or early clinical innovations

• Biotech ventures with large unmet clinical needs

Teams may apply before formal company incorporation — ideal for researchers preparing to spin out.

Why This Programme Matters

BioVenture Builder fills a critical gap between early academic discovery and seed-stage biotech investment. The programme gives founders the time, structure and expertise needed to validate their approach, build a compelling venture case and prepare for the next phase of growth.

For many LS@W Venture Challenge alumni, BioVenture Builder offers a natural next step following initial market validation.

Apply Now

More information and the application form are available on BOM's website:

Click Here

LifeSciences@Work proudly highlights initiatives that strengthen the Dutch biotech ecosystem and help scientists build ventures capable of real clinical and societal impact.